← All stories
Deals
Curium acquires Abscint SA, expanding PET radiodiagnostic pipeline in oncology
Acquisition adds ABS-011, an investigational Phase 2b gallium-68-labeled PET radiodiagnostic tracer targeting HER2 Transaction strengthens Curium radiodiagnostic capabilities and oncology footprint, including in breast and gastric cancers B…
Covered by 1 outlet
All coverage · 1 article